National Jewish Medical and Research Center discharged patient Andrew Speaker at 6 a.m. Thursday, July 26, after the successful completion of his in-patient treatment for multi-drug-resistant tuberculosis.
The World Bank today announced it will work with Jamaican authorities to prepare a Second HIV/AIDS Prevention and Control Project based on the current program?s successful performance and ratings.
The Department of Health is offering screening to students at a Perth primary school who may have had contact with a student who has tuberculosis.
Weather conditions permitting, spraying to control adult mosquito populations will be conducted during the evening hours on Monday, July_30, in Springettsbury and Lower Windsor townships, York County.
A new study has revealed more about how the medication ketamine, when used experimentally for depression, relieves symptoms of the disorder in hours instead of the weeks or months it takes for current antidepressants to work.
Using a quantitative high-throughput screening strategy, researchers at the National Institutes of Health (NIH) have identified three new classes of small molecules that may prove useful for treating Gaucher disease, an inherited disorder that disrupts a cell?s ability to break down and dispose of certain cellular waste products.
Manchester United stars Ryan Giggs, Rio Ferdinand and Dong Fangzhuo took time out of the club?s Far East Tour for a meeting with three children whose lives have been affected by HIV/AIDS and have suffered from stigma and discrimination as a result.
The U.S. Food and Drug Administration announced that it is permitting the restricted use of Zelnorm (tegaserod maleate) under a treatment investigational new drug (IND) protocol to treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC) in women younger than 55 who meet specific guidelines.
On July_24, 2007 the U.S. Food and Drug Administration (FDA) was informed by Targeted Genetics Corporation of Seattle about the death of a patient who received an investigational gene therapy product in a clinical trial for the treatment of active inflammatory arthritis.
Anxious or depressed mothers-to-be are at increased risk of having children who will experience sleep problems in infancy and toddlerhood, finds a study that published this month in Early Human Development.